NORTHRIDGE, Calif., Nov. 5, 2026 /PRNewswire/ -- MiniMed (Nasdaq: MMED), a global leader in diabetes technology, today announced that Chad Spooner, EVP, Chief Financial Officer, will discuss and answer questions on the company at the following investor conferences:
9th Annual Evercore Healthcare Conference
Tuesday, December 1, 2026, at 10:50 a.m. EST / 7:50 a.m. PST
Citi's 2026 Global Healthcare Conference
Wednesday, December 2, 2026, at 11:00 a.m. EST / 8:00 a.m. PST
Piper Sandler 38th Annual Healthcare Conference
Thursday, December 3, 2026, at 11:30 a.m. EST / 8:30 a.m. PST
Live webcasts and replays will be accessible on the MiniMed Investor Relations website: investors.minimed.com/events.
About MiniMed
MiniMed is a global leader in insulin delivery, constantly advancing therapies that support people with diabetes in more than 80 countries. Our full-stack, integrated ecosystem, including our insulin delivery systems, CGMs, algorithms, and easy-to-use app experience, is designed to work seamlessly together, supported by white-glove, wrap-around service. For over 40 years, we've pioneered therapies people can rely on by anticipating needs, reducing burden, and helping make life with diabetes easier. Our mission is to make every day a better day for people with diabetes.
Any forward-looking statements are subject to risks and uncertainties such as those described in MiniMed's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.
SOURCE MiniMed